• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥大细胞作为乳腺癌分子亚型的指标和预后标志物

Mast Cells as an Indicator and Prognostic Marker in Molecular Subtypes of Breast Cancer.

作者信息

Carpenco Ecaterina, Ceauşu Raluca Amalia, Cimpean Anca Maria, Gaje Puşa Nela, Șaptefraţi Lilian, Fulga Veaceslav, David Valeriu, Raica Marius

机构信息

Department of Histology, Cytology and Embryology, Nicolae Testemițanu State University of Medicine and Pharmacy, Chișinău, Republic of Moldova.

Laboratory of Morphology, Nicolae Testemițanu State University of Medicine and Pharmacy, Chișinău, Republic of Moldova.

出版信息

In Vivo. 2019 May-Jun;33(3):743-748. doi: 10.21873/invivo.11534.

DOI:10.21873/invivo.11534
PMID:31028192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6559908/
Abstract

BACKGROUND/AIM: Mast cells (MCs) represent the most controversial non-malignant element of the tumor microenvironment. Our aim was to study how MCs density and distribution (intratumoral-MCit versus peritumoral-MCpt) relate to tumor grade and molecular subtypes.

MATERIALS AND METHODS

MCs tryptase immunohistochemistry was performed on 80 cases of breast carcinomas.

RESULTS

For Luminal A tumors, a partial correlation was detected between MCit and progesterone receptor (PR) (p=0.005). Luminal B tumors showed a significant correlation between MCpt and age (p=0.009), estrogen receptor (ER) (p=0.017) and PR (p=0.035). MCit and MCpt were strongly interrelated in this subtype (p=0.002) and in triple-negative breast cancers (p=0.002). In HER2 subtype, MCpt tumors were significantly correlated with HER2 (p=0.044). In G2 tumors, MCpt correlated with ER (p=0.015) and PR (p=0.038) while in G3 tumors ER correlated with both MCit (p=0.009) and MCpt (p=0.000487) tumors.

CONCLUSION

MCs dynamics are strongly influenced by hormone receptors and HER2 status. MCit increased in aggressive tumor types and is a worse prognostic factor.

摘要

背景/目的:肥大细胞(MCs)是肿瘤微环境中最具争议的非恶性成分。我们的目的是研究MCs密度和分布(瘤内-MCit与瘤周-MCpt)与肿瘤分级和分子亚型之间的关系。

材料与方法

对80例乳腺癌进行MCs嗜酸性粒细胞阳离子蛋白免疫组化检测。

结果

对于Luminal A型肿瘤,MCit与孕激素受体(PR)之间存在部分相关性(p = 0.005)。Luminal B型肿瘤显示MCpt与年龄(p = 0.009)、雌激素受体(ER)(p = 0.017)和PR(p = 0.035)之间存在显著相关性。在该亚型(p = 0.002)和三阴性乳腺癌(p = 0.002)中,MCit和MCpt密切相关。在HER2亚型中,MCpt肿瘤与HER2显著相关(p = 0.044)。在G2级肿瘤中,MCpt与ER(p = 0.015)和PR(p = 0.038)相关,而在G3级肿瘤中,ER与MCit(p = 0.009)和MCpt(p = 0.000487)肿瘤均相关。

结论

MCs动态受到激素受体和HER2状态的强烈影响。MCit在侵袭性肿瘤类型中增加,是一个更差的预后因素。

相似文献

1
Mast Cells as an Indicator and Prognostic Marker in Molecular Subtypes of Breast Cancer.肥大细胞作为乳腺癌分子亚型的指标和预后标志物
In Vivo. 2019 May-Jun;33(3):743-748. doi: 10.21873/invivo.11534.
2
The relationship between breast cancer molecular subtypes and mast cell populations in tumor microenvironment.乳腺癌分子亚型与肿瘤微环境中肥大细胞群体之间的关系。
Virchows Arch. 2017 May;470(5):505-515. doi: 10.1007/s00428-017-2103-5. Epub 2017 Mar 18.
3
Quantitative mast cell analysis and hormone receptor study (ER, PR and HER2/neu) in invasive carcinoma of breast.定量分析乳腺浸润性癌中的肥大细胞及激素受体(ER、PR 和 HER2/neu)。
Indian J Pathol Microbiol. 2020 Apr-Jun;63(2):200-204. doi: 10.4103/IJPM.IJPM_155_19.
4
Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study.阿尔及利亚女性分子乳腺癌亚型的分布及其与临床和肿瘤特征的相关性:一项基于人群的研究。
Breast Dis. 2015;35(2):95-102. doi: 10.3233/BD-150398.
5
Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013.除了根据2013年圣加仑会议定义的乳腺癌亚型外,组织学分级还提供了重要的预后信息。
Acta Oncol. 2017 Jan;56(1):68-74. doi: 10.1080/0284186X.2016.1237778. Epub 2016 Oct 20.
6
Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.白人女性乳腺癌生存中乳腺癌亚型、Ki-67 增殖指数、年龄和病理肿瘤特征的预后价值。
Breast J. 2013 Jan-Feb;19(1):22-30. doi: 10.1111/tbj.12059. Epub 2012 Dec 13.
7
Breast Cancer Survival Analysis Based on Immunohistochemistry Subtypes (ER/PR/HER2): a Retrospective Cohort Study.基于免疫组织化学亚型(ER/PR/HER2)的乳腺癌生存分析:一项回顾性队列研究。
Arch Iran Med. 2016 Oct;19(10):680-686.
8
Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery.保乳手术后最大直径小于或等于 2cm 的乳腺癌免疫组化定义亚型的长期预后
J Surg Res. 2019 Apr;236:288-299. doi: 10.1016/j.jss.2018.11.028. Epub 2018 Dec 27.
9
Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort.7 年随访后年轻和老年女性全国队列中临床亚型的乳腺癌特异性生存。
Int J Cancer. 2019 Mar 15;144(6):1251-1261. doi: 10.1002/ijc.31950. Epub 2018 Dec 3.
10
Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.使用定量氟-18氟脱氧葡萄糖/正电子发射断层扫描成像参数比较三阴性乳腺癌与雌激素受体阳性/孕激素受体阳性/人表皮生长因子受体2阴性乳腺癌:一种对疾病特征描述可能有用的方法。
Cancer. 2008 Mar 1;112(5):995-1000. doi: 10.1002/cncr.23226.

引用本文的文献

1
Mast cell heparanase promotes breast cancer stem-like features via MUC1/estrogen receptor axis.肥大细胞乙酰肝素酶通过 MUC1/雌激素受体轴促进乳腺癌干细胞样特征。
Cell Death Dis. 2024 Sep 30;15(9):709. doi: 10.1038/s41419-024-07092-9.
2
Integrative analyses of genes associated with oxidative stress and cellular senescence in triple-negative breast cancer.三阴性乳腺癌中与氧化应激和细胞衰老相关基因的综合分析
Heliyon. 2024 Jul 16;10(14):e34524. doi: 10.1016/j.heliyon.2024.e34524. eCollection 2024 Jul 30.
3
Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics.在乳腺癌进展过程中肿瘤微环境中的细胞相互作用:新前沿及其对新型治疗的意义。
Front Immunol. 2024 Mar 12;15:1302587. doi: 10.3389/fimmu.2024.1302587. eCollection 2024.
4
Integrative analysis of homologous recombination repair patterns unveils prognostic signatures and immunotherapeutic insights in breast cancer.同源重组修复模式的综合分析揭示了乳腺癌的预后特征和免疫治疗见解。
J Appl Genet. 2024 Dec;65(4):823-838. doi: 10.1007/s13353-024-00848-1. Epub 2024 Mar 13.
5
Mast Cells as a Target-A Comprehensive Review of Recent Therapeutic Approaches.肥大细胞作为靶点:近期治疗方法的综合述评
Cells. 2023 Apr 19;12(8):1187. doi: 10.3390/cells12081187.
6
Associations of breast cancer related exposures and gene expression profiles in normal breast tissue-The Norwegian Women and Cancer normal breast tissue study.乳腺癌相关暴露与正常乳腺组织基因表达谱的关联——挪威妇女与癌症正常乳腺组织研究。
Cancer Rep (Hoboken). 2023 Apr;6(4):e1777. doi: 10.1002/cnr2.1777. Epub 2023 Jan 8.
7
New C3H Kit cancer mouse model develops late-onset malignant mammary tumors with high penetrance.新型 C3H Kit 癌症小鼠模型可发展出具有高外显率的迟发性恶性乳腺肿瘤。
Sci Rep. 2022 Nov 17;12(1):19793. doi: 10.1038/s41598-022-23218-5.
8
Mast cell density in the primary tumor predicts lymph node metastases in patients with breast cancer.原发肿瘤中的 mast cell 密度可预测乳腺癌患者的淋巴结转移。
Rom J Morphol Embryol. 2022 Jan-Mar;63(1):129-135. doi: 10.47162/RJME.63.1.13.
9
Association of mast cell density, microvascular density and endothelial area with clinicopathological parameters and prognosis in canine mammary gland carcinomas.犬乳腺肿瘤中肥大细胞密度、微血管密度和内皮面积与临床病理参数及预后的相关性研究。
Acta Vet Scand. 2022 Jun 27;64(1):14. doi: 10.1186/s13028-022-00633-2.
10
Few, but Efficient: The Role of Mast Cells in Breast Cancer and Other Solid Tumors.寥寥数枚,却功效显著:肥大细胞在乳腺癌及其他实体瘤中的作用。
Cancer Res. 2022 Apr 15;82(8):1439-1447. doi: 10.1158/0008-5472.CAN-21-3424.

本文引用的文献

1
Estrogen receptor-beta is a potential target for triple negative breast cancer treatment.雌激素受体-β是三阴性乳腺癌治疗的一个潜在靶点。
Oncotarget. 2018 Sep 21;9(74):33912-33930. doi: 10.18632/oncotarget.26089.
2
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
3
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.人表皮生长因子受体 2 检测在乳腺癌中的应用:美国临床肿瘤学会/美国病理学家学院临床实践指南的重点更新。
J Clin Oncol. 2018 Jul 10;36(20):2105-2122. doi: 10.1200/JCO.2018.77.8738. Epub 2018 May 30.
4
Estrogen is an important mediator of mast cell activation in ovarian endometriomas.雌激素是卵巢子宫内膜异位症中 mast cell 激活的重要介质。
Reproduction. 2018 Jan;155(1):73-83. doi: 10.1530/REP-17-0457. Epub 2017 Oct 26.
5
Immunoprofiling of human uterine mast cells identifies three phenotypes and expression of ERβ and glucocorticoid receptor.人类子宫肥大细胞的免疫分析确定了三种表型以及雌激素受体β和糖皮质激素受体的表达。
F1000Res. 2017 May 12;6:667. doi: 10.12688/f1000research.11432.2. eCollection 2017.
6
Mast cells in breast cancer angiogenesis.乳腺癌血管生成中的肥大细胞。
Crit Rev Oncol Hematol. 2017 Jul;115:23-26. doi: 10.1016/j.critrevonc.2017.04.009. Epub 2017 Apr 27.
7
Are Mast Cells MASTers in Cancer?肥大细胞是癌症的“主宰”吗?
Front Immunol. 2017 Apr 12;8:424. doi: 10.3389/fimmu.2017.00424. eCollection 2017.
8
The relationship between breast cancer molecular subtypes and mast cell populations in tumor microenvironment.乳腺癌分子亚型与肿瘤微环境中肥大细胞群体之间的关系。
Virchows Arch. 2017 May;470(5):505-515. doi: 10.1007/s00428-017-2103-5. Epub 2017 Mar 18.
9
The associations between mast cell infiltration, clinical features and molecular types of invasive breast cancer.肥大细胞浸润、浸润性乳腺癌的临床特征与分子类型之间的关联。
Oncotarget. 2016 Dec 6;7(49):81661-81669. doi: 10.18632/oncotarget.13163.
10
Histological changes in the vulva and vagina from ovariectomised rats undergoing oestrogen treatment.接受雌激素治疗的去卵巢大鼠外阴和阴道的组织学变化。
Folia Morphol (Warsz). 2016;75(4):467-473. doi: 10.5603/FM.a2016.0026. Epub 2016 Nov 10.